Clinical trial
S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent…
NCT00003127 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003127 |
|---|---|
| Title | S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer |
| Official title | Phase II Trial of Paclitaxel and Carboplatin With Amifostine in Advanced Recurrent or Refractory Endometrial Adenocarcinoma |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Endometrial Cancer |
| Intervention type | Drug |
| Interventions | amifostine trihydrate, carboplatin, paclitaxel |
| Enrollment | 57 |
| Start date | Feb 1, 1998 |
| Primary completion | Apr 1, 2003 |
| Completion | Jul 1, 2004 |
| First posted | Jun 24, 2004 |
| Last update posted | Jun 14, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: